QQ客服 官方微博 反馈留言

	Acitretin combined with NB-UVB in the treatment of cutaneous CD30-positive anaplastic large cell lymphoma
	Xu, Hui[1]; Liu, Qi[2]; Li, Yu-Mei[3]; Ma, Hong[4]; Hu, Hui-Min[5]
刊名	DERMATOLOGIC THERAPY
	2019
卷号	32期号:2页码:e12834
关键词	acitretin cutaneous CD30-positive anaplastic large cell lymphoma NB-UVB
ISSN号	1396-0296
DOI	http://dx.doi.org/10.1111/dth.12834
URL标识	查看原文
收录类别	SCI(E) ; PUBMED
WOS记录号	WOS:000462941000048
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5324719
专题	江苏大学
作者单位	1.[1]Jiangsu Univ, Affiliated Hosp, Dept Dermatol, 438 Jie Fang Lu Rd, Zhenjiang 212001, Jiangsu, Peoples R China.,Jiangsu Univ, Lab Regenerat Med, Zhenjiang, Jiangsu, Peoples R China. 2.[2]Jiangsu Univ, Affiliated Hosp, Dept Dermatol, 438 Jie Fang Lu Rd, Zhenjiang 212001, Jiangsu, Peoples R China.,Jiangsu Univ, Lab Regenerat Med, Zhenjiang, Jiangsu, Peoples R China. 3.[3]Jiangsu Univ, Affiliated Hosp, Dept Dermatol, 438 Jie Fang Lu Rd, Zhenjiang 212001, Jiangsu, Peoples R China.,Jiangsu Univ, Lab Regenerat Med, Zhenjiang, Jiangsu, Peoples R China. 4.[4]Jiangsu Univ, Affiliated Hosp, Dept Dermatol, 438 Jie Fang Lu Rd, Zhenjiang 212001, Jiangsu, Peoples R China.,Jiangsu Univ, Lab Regenerat Med, Zhenjiang, Jiangsu, Peoples R China. 5.[5]Jiangsu Univ, Affiliated Hosp, Dept Dermatol, 438 Jie Fang Lu Rd, Zhenjiang 212001, Jiangsu, Peoples R China.,Jiangsu Univ, Lab Regenerat Med, Zhenjiang, Jiangsu, Peoples R China.
推荐引用方式 GB/T 7714	Xu, Hui[1],Liu, Qi[2],Li, Yu-Mei[3],et al. Acitretin combined with NB-UVB in the treatment of cutaneous CD30-positive anaplastic large cell lymphoma[J]. DERMATOLOGIC THERAPY,2019,32(2):e12834.
APA	Xu, Hui[1],Liu, Qi[2],Li, Yu-Mei[3],Ma, Hong[4],&Hu, Hui-Min[5].(2019).Acitretin combined with NB-UVB in the treatment of cutaneous CD30-positive anaplastic large cell lymphoma.DERMATOLOGIC THERAPY,32(2),e12834.
MLA	Xu, Hui[1],et al."Acitretin combined with NB-UVB in the treatment of cutaneous CD30-positive anaplastic large cell lymphoma".DERMATOLOGIC THERAPY 32.2(2019):e12834.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。